Early Phase 1 Peripheral Neuropathy Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been clinically diagnosed with hereditary spastic paraplegia (a condition affecting movement and muscle stiffness in the legs).
• People whose condition has been specifically identified as Spastic Paraplegia Type 56 (SPG56), confirmed by genetic testing showing a mutation in the CYP2U1 gene.
• People who are willing to take part in a clinical trial and are able to understand and follow the study requirements.

Who may not be able to join:

• People who have a known allergy to any of the medications being used in this study.
• People who have another neurological condition (a condition affecting the brain or nervous system) that could interfere with how the study results are measured.
• People who have had a significant medical condition in the past year, such as heart disease, cancer, a blood disorder, liver disease, or kidney disease.
• Women who are pregnant, breastfeeding, or who are unable to use a reliable method of contraception during the trial.
• People who have taken part in another clinical drug trial and received an experimental medication within the past 30 days.
• People who may have difficulty following the study requirements, or who have other factors that the trial site considers unsuitable for participation (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.